The Flow Cytometry market research report empowers a market player not exclusively to design yet additionally execute rewarding Flow Cytometry market procedures dependent on developing business sector needs by underscoring driving contender’s vital moves which incorporate ongoing mergers, adventures, acquisitions, business extension, item dispatches, marking, and limited time exercises. Moreover, the report envelops the key vital advancements of the market involving new item dispatch, inquire about and improvement, organizations, acquisitions and mergers, coordinated efforts and joint endeavors understandings, and territorial development of primary players in the market on the worldwide and provincial level. It focuses more on current business and developments, future framework changes, and open sections for the Flow Cytometry market.
Access Free Sample Copy of Research Report: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-flow-cytometry-market
The Flow Cytometry market research report plots an intentional review of macroeconomic signs, parent affiliations, and new startup adventures. The report consolidates the latest mechanical updates and new releases to associate with clients to setup, settle on smart business decisions, and complete their future required executions. The definite figures and the graphical depiction of the Flow Cytometry market are included to plot a clear picture of trends and techniques. Exceptional data on different specifications, purchase analysis, their purchasing cost, volume, and value investigation, and profound bits of knowledge on the main providers have additionally been given in this report to the readers.
Global flow cytometry market is expected to reach at a CAGR of 8.3% in the forecast period of 2018 to 2025.
Competitive Analysis: Global Flow Cytometry Market
Some of the major players operating in this market are Bio-Rad Laboratories, Inc., Miltenyi Biotec Sysmex Partec GmbH, BIOMÉRIEUX, Mechatronics,, Apogee Flow Systems Ltd., Stratedigm, Inc., Sony Biotechnology Inc., BD., Thermo Fisher Scientific Inc., Merck KGaA, ACEA BIO, Agilent Technologies , Luminex Corporation. , Enzo Life Sciences, Inc., Beckman Coulter, Inc., Takara Bio Inc. among others.
Table of Contents
5.Global, By Component
Get detailed toc @ https://databridgemarketresearch.com/toc/?dbmr=global-flow-cytometry-market
Segmentation: Global Flow Cytometry Market
Global flow cytometry market is segmented into four notable segments which are technology, products, end user and application.
On the basis of technology, the market is segmented into cell-based flow cytometry and bead-based flow cytometry. Cell-based flow cytometry is dominating the market and bead-based flow cytometry segment is growing at the highest CAGR in the forecast period of 2018 to 2025.
In April 2018, Merck KGaA (Germany) launched its new Cell Stream benchtop flow cytometry system which is a compressed, customizable flow cytometer that use a camera for detection. It is a unique optics system and design provides researchers with unparalleled sensitivity and flexibility when analyzing cells and submicron particles. With this launch of the product company has expanded their product line in flow cytometers.
On the basis of products, the market is segmented into categorized into reagents and consumables, flow cytometry instruments, accessories and services. The segment reagents and consumables are further sub segmented into antibodies, dyes, beads and others. The segment flow cytometry instruments are further sub segmented into cell analyzers and cell sorters. The segment services are further sub segmented into filters, laser devices, detectors and others. Flow cytometry instruments segment is growing at the highest CAGR in the forecast period of 2018 to 2025.
In February 2014, Bio-Rad Laboratories, Inc. (U.S.), announced the launch of its ReadiLink antibody labeling kits, one of the market’s simplest antibody conjugation solution for labeling microscale amounts (50-100 µg) of antibody. These kits are ideal for researchers interested in labelling their own antibodies for flow cytometry and cell sorting applications.
On the basis of application, the market is segmented into research applications, clinical application and industrial applications. Research application market is further sub segmented into pharmaceutical and biotechnology, immunology, apoptosis, cell sorting/ screening, cell cycle analysis, cell transfection/viability, cell counting, other research applications. Pharmaceutical and biotechnology are further segmented into drug discovery, stem cell research, in vitro toxicity testing. The clinical applications are further sub segmented into cancer, hematology, immunodeficiency diseases, organ transplantation, and other clinical applications. Clinical application segment is growing at the highest CAGR in the forecast period of 2018 to 2025.
In September 2017, Beckman Coulter, Inc. (U.S.), has launch their first flow cytometry CytoFLEX LX for the cancer researchers which has the visible spectrum in a standard configuration. From this launch of the product they have expanded their business in flow cytometry.
On the basis of end user, the market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals, clinical testing laboratories, blood bank and others. Academic & research institutes segment is growing at the highest CAGR in the forecast period of 2018 to 2025.
In July 2017, Beckman Coulter, Inc. (U.S.), has received U.S. FDA approval for its clinical flow cytometry product, the Navios EX flow cytometer, to be used in the clinical laboratory in the US. The Navios EX delivers accurate, high complexity immunophenotyping using Tetra reagents. The compact, 10-color Navios EX incorporates the advanced optics and laser technology of the company’s award-winning CytoFLEX research flow cytometer. From this clearance Beckman Coulter, Inc. has enhanced their product portfolio in flow cytometry.
Any inquiry, Speak to Our Expert: https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-flow-cytometry-market
In August 2018, Sysmex Partec GmbH (Germany) announced the notice about clearance of WHO prequalification. This testing system helps diagnose and monitor the immune status of people infected with HIV by checking CD4 in human blood samples. The CyFlow Counter System, which has received WHO prequalification, comprises a compact, robust desktop flow cytometer (CyFlow Counter) and a group of related reagents (CD4 easy count kit/CD4% easy count kit).
In September2017, Miltenyi Biotec GmbH (Germany) launched a fully automated high-throughput flow cytometry MACSQuant X which handles 384-well plates in less than 60 minutes giving users fast, reliable, and reproducible results. Launching these products has expanded the flow cytometry product line of company.
In November 2016, Sysmex Partec GmbH (Germany) launched the RF-500 flow cytometer, its new product for the research and industrial domains. The instrument will be on exhibit with the Molecular Biology Society of Japan and the Japanese Society for Immunology. The states of individual cells and the interactions between cells have a significant impact on phenomena (such as disease states) that occur within the body.
In September 2016, Miltenyi Biotec GmbH (Germany) offered flow cytometry antibodies in a concentrated format of 2 μL of antibody per test. This is because of increasing demand for smaller pipetting volumes for multicolour panels with many antibodies.
Access Full Report @ https://databridgemarketresearch.com/reports/global-flow-cytometry-market
Data Bridge Market Research